Trexquant Investment LP Enanta Pharmaceuticals Inc Transaction History

Trexquant Investment LP

$8.9 Billion
Q3 2025

A detailed history of Trexquant Investment LP transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Trexquant Investment LP holds 127,363 shares of ENTA stock, worth $1.54 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

127,363

Previous 264,958 51.93%

Holding current value

$1.54 Million

Previous $2 Million 23.91%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$6.49 - $15.16 $892,991 - $2.09 Million	-137,595 Reduced 51.93%	127,363 $1.52 Million
Q2 2025 Aug 12, 2025	SELL	$4.26 - $7.95 $106,930 - $199,552	-25,101 Reduced 8.65%	264,958 $2 Million
Q1 2025 May 14, 2025	BUY	$4.82 - $8.49 $742,786 - $1.31 Million	154,105 Added 113.35%	290,059 $1.6 Million
Q4 2024 Feb 12, 2025	BUY	$5.75 - $12.99 $385,480 - $870,849	67,040 Added 97.28%	135,954 $781,000
Q3 2024 Nov 12, 2024	SELL	$10.05 - $16.54 $100,590 - $165,548	-10,009 Reduced 12.68%	68,914 $714,000

Q2 2024 Aug 13, 2024	SELL	$11.43 - $17.02 $191,063 - $284,506	-16,716 Reduced 17.48%	78,923 $1.02 Million
Q1 2024 May 14, 2024	SELL	$10.08 - $17.46 $231,567 - $401,108	-22,973 Reduced 19.37%	95,639 $1.67 Million
Q4 2023 Feb 09, 2024	SELL	$8.18 - $10.78 $114,102 - $150,370	-13,949 Reduced 10.52%	118,612 $1.12 Million
Q3 2023 Nov 13, 2023	BUY	$11.09 - $22.13 $1.47 Million - $2.93 Million	132,561 New	132,561 $1.48 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $66,157 - $97,639	-1,370 Reduced 21.91%	4,882 $253,000
Q2 2022 Aug 11, 2022	BUY	$38.13 - $76.93 $238,388 - $480,966	6,252 New	6,252 $296,000
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $326,437 - $466,736	-7,958 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$43.76 - $53.11 $348,242 - $422,649	7,958 New	7,958 $350,000
Q1 2021 May 13, 2021	SELL	$41.69 - $54.95 $296,999 - $391,463	-7,124 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$41.16 - $47.47 $350,436 - $404,159	-8,514 Reduced 54.44%	7,124 $300,000
Q3 2020 Nov 06, 2020	BUY	$43.36 - $53.53 $338,294 - $417,641	7,802 Added 99.57%	15,638 $716,000
Q2 2020 Aug 07, 2020	BUY	$46.37 - $57.58 $363,355 - $451,196	7,836 New	7,836 $393,000
Q3 2019 Nov 08, 2019	SELL	$60.08 - $88.17 $229,745 - $337,162	-3,824 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$81.3 - $97.35 $908,934 - $1.09 Million	-11,180 Reduced 74.51%	3,824 $323,000
Q1 2019 May 13, 2019	BUY	$69.08 - $105.66 $1.04 Million - $1.59 Million	15,004 New	15,004 $1.43 Million
Q3 2018 Nov 09, 2018	SELL	$85.46 - $126.37 $450,032 - $665,464	-5,266 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$81.85 - $120.51 $431,022 - $634,605	5,266 New	5,266 $610,000
Q1 2018 May 03, 2018	SELL	$57.91 - $92.15 $499,184 - $794,333	-8,620 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$45.65 - $59.37 $393,503 - $511,769	8,620	8,620 $506,000

Others Institutions Holding ENTA

# of Institutions

128

Shares Held

19.4M

Call Options Held

290K

Put Options Held

61.7K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $250M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Enanta Pharmaceuticals Inc Transaction History